18th Aug 2021 14:26
Avacta Group PLC - Wetherby, England-based cancer immunotherapies developer - Hires Mark Goldberg as non-executive director, effective immediately. Goldberg is a medical oncologist and haematologist on the faculty of Brigham & Women's Hospital and Harvard Medical School. He is the past-chair of the Eastern New England Area Board of the American Cancer Society.
Current stock price: 106.49 pence, up 1.4% on Wednesday
Year-to-date change: down 6.6%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Avacta Group